Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding. Alpha Wave Ventures led the round with participation from existing investors AXA IM…
Continue Reading
What You Should Know:
– Biolinq, a healthcare technology company focused on developing precision multi-analyte biosensors to improve metabolic health raises $100M in Series C financing round led by Alpha Wave Ventures, with participation from…
Continue Reading
Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale
Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device
$58 Million in Funding…
